-
Americans to get one-time payment from new $250,000 401k settlement – the two criteria you need to apply
12 May 2024 14:22 GMT
… Americans are eligible for a payment from a $250,000 … been agreed to by the pharmaceutical company to the sum of $250 … plan will automatically receive a payment to their investment accounts.
… settle class actions - offering payment to class members who …
-
Breaking: Third Circuit Declares Mallinckrodt’s Future Royalty Payment Obligations Dischargeable – Caution, Warning, and Options
10 May 2024 19:22 GMT
… medication called Acthar Gel from pharmaceutical company Sanofi-Aventis. Pursuant to the … definition of “claim,” the royalty payments were therefore dischargeable.
Sanofi next … contingent, unsecured claim for royalty payments that was subsequently discharged.
…
-
Americans can claim one-time payment up to $300 from $15 million pet settlement – and there’s a single criteria
10 May 2024 16:18 GMT
… a lawsuit against two animal pharmaceutical companiesCredit: Getty
2
Americans whose … further legal costs.
Direct payments are headed out to … 4, 2024.
POTENTIAL AWARD
Payment amounts for customers will … class actions - offering payment to class members who …
-
R.I. health care spending skyrocketed after COVID. Now it’s coming back down to Earth.
13 May 2024 10:43 GMT
… with rising drug prices from pharmaceutical companies takes money away from government … with the highest per unit payment, they cost significantly less when …
-
Blackstone to Take Japan Drug Trial Firm Private in Management Buyout
13 May 2024 10:49 GMT
… clinical trial management services to pharmaceutical companies that need to run drug … the US and partnering with drugmakers to run trials in Japan … said it would acquire a payment service provider from Sony Group …
-
AC Immune and Takeda Sign Exclusive Option and License Agreement for Active Immunotherapy Targeting Amyloid Beta for Alzheimer’s Disease
13 May 2024 10:00 GMT
…
AC Immune to receive upfront payment of $100 million upon closing … strategic partnerships with leading global pharmaceutical companies, resulting in substantial non-dilutive … .5 billion in potential milestone payments. SupraAntigen® is a registered trademark …
-
AC Immune Reports First Quarter 2024 Financial Results and Provides a Corporate Update
13 May 2024 10:05 GMT
… million upfront and total potential payments for option exercise and … strategic partnerships with leading global pharmaceutical companies, resulting in substantial non-dilutive … .5 billion in potential milestone payments plus royalties. SupraAntigen® is …
-
AC Immune and Takeda Sign Exclusive Option and License Agreement for Active Immunotherapy Targeting Amyloid Beta for Alzheimer’s Disease
13 May 2024 10:08 GMT
… Immune will receive an upfront payment of $100 million and be … strategic partnerships with leading global pharmaceutical companies, resulting in substantial non-dilutive … .5 billion in potential milestone payments.
SupraAntigen® is a registered trademark …
-
Royalty Pharma to Present at Upcoming Investor Conferences
13 May 2024 12:15 GMT
… biotechnology companies to leading global pharmaceutical companies. Royalty Pharma has assembled a … royalties which entitles it to payments based directly on the top …
-
Shionogi, Maze Therapeutics announce exclusive worldwide license agreement for MZE001, an oral GYS1 inhibitor to treat Pompe disease
13 May 2024 09:49 GMT
… ., a leading global research-driven pharmaceutical company, and Maze Therapeutics, Inc., a … will be eligible for milestone payments based on development, regulatory and … a leading global research-driven pharmaceutical company dedicated to bringing benefits to …